Page 3 - Glenmark

Glenmark bets big on innovation

The company expects R&D costs to be 11% of sales, plans nine drug applications and biologic entities

Glenmark announces tie up for anti cancer drug

As per the terms of agreement Particle Sciences Inc will develop the product exclusively for Glenmark

Glenmark Pharma Q1 profit up 24%

Posts Rs 227 cr profit; company's consolidated revenue jumps 18% to Rs 1,943 cr

Glenmark plans to raise $200 million

The company is looking for IFC to be a long-term partner, when it is developing new products that will take several years to be commercially launched

Glenmark to ramp up respiratory business with new inhaler

The drug maker launched the country's first digital dose inhaler today and plans to launch an another inhaler over next six months